Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 August 2018 Photo Sonia Small
Karen Lazenby WomenofKovsies
Dr Karen Lazenby strives for a stronger, rule-based, and consistent governance structure.

A transformed University of the Free State (UFS) will be one that promotes social justice in everything it does, a university where its diverse people feel a sense of common purpose and engagement. The UFS is developing this through its Integrated Transformation Plan (ITP) introduced in January 2017. 

“The majority of the current systems and processes in student administration at the university are still manual. This lack of automation leads to inconsistencies and service failures,” says Dr Karen Lazenby. As Registrar for Systems and Administration, Dr Lazenby is responsible for ensuring a smooth and efficient student lifecycle across all three campuses. 

With the ITP, the Governance: Systems and Administration work stream strives to have a stronger, rule-based, and consistent governance structure with a single line of accountability in student administration across all faculties and relevant support departments on the three campuses. By ensuring this ease of use and access there will be an integrated student experience and greater empowerment of students.

“Our focus is on automation and self-services for students (such as the time-table, requests for additional and ad hoc exams and appeals), to ensure transparency and accessibility of rules and policies, decisions relating to admission, progression rules, awarding of qualifications and graduation and faculty and general rules,” Dr Lazenby said.  It will also entail the optimisation of PeopleSoftCampus (the Enterprise Resource Planning system).

“Through this automation, I would also like to get the university’s student administration to such a level that academic staff can focus their energy on teaching and research and student administration staff can focus more on quality assurance,” said Dr Lazenby.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept